Abstract

A novel visible-light-driven type II p-n heterojunction CAU-17/MoS2 photocatalytic antifouling biocide was prepared and indicated significant inhibition against the most pharmaceutically recognized harmful microorganisms: gram-positive Staphylococcus aureus (S. aureus), gram-negative Escherichia coli (E. coli) and the drug-resistant bacterium methicillin-resistant Staphylococcus aureus (MRSA). The antimicrobial mechanism is attributed to the production of reactive oxygen species (ROS) such as •OH, 1O2 due to the photocatalytic properties of CAU-17/MoS2 heterojunction. The electron-hole complexation efficiency of the nanocomposites was analyzed using photoluminescence spectroscopy and characterized using electron microscope. It was found that the heterojunction structure of the nanocomposites provided multiple charge transfer channels to significantly improve the transporting and separating efficiency for the photo-induced electron-hole pairs, which consequently facilitated the production of ROS. Given the promising antimicrobial effects, further investigation on the broader application of CAU-17/MoS2 biocides is needed to test the cytotoxicity, as well as the post-bacteriostatic wound healing effect upon animal models.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call